Ca
Non verificato

CareDx, Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaMedicina - VarieSaluteSanità
05/03/2026
Eventi
Industria
Sanità
Software
Associazioni/Professionisti
Information Technology
Tecnica
Management
Tecnologie Varie
Salute
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
1.00
27/02/2026
Finanza
Scienza
Medicina - Varie
Cardiologia
Sanità
Biotecnologia
Farmaceutica
Salute
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
24/02/2026
Mercato del lavoro
Medicina - Varie
Salute
Cardiologia
Sanità
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
1.00
24/02/2026
Mercato azionario
Sanità
Medicina - Varie
Salute
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
1.00
18/02/2026
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
1.00
12/02/2026
Scienza
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Tecnica
Sanità
Medicina - Varie
Biotecnologia
Salute
Industria
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
1.00
10/02/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Medicina - Varie
Salute
Attrezzature medico-sanitarie
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
1.00
03/02/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Web e Social Network
Telefonia e Varie
Eventi
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
1.00
03/02/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Web e Social Network
Telefonia e Varie
Eventi
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0